What is the average price target for AXA SA (CS.PA) stock?
30 analysts have analysed CS.PA and the average price target is 46.89 EUR. This implies a price increase of 15.74% is expected in the next year compared to the current price of 40.51.
EPA:CS • FR0000120628
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AXA SA (CS.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | Berenberg | Maintains | Buy -> Buy |
| 2025-12-12 | Berenberg | Maintains | Buy -> Buy |
| 2024-08-08 | LANDESBANK BADEN-WUERTTEMBERG | Maintains | Hold -> Hold |
| 2023-12-22 | Berenberg | Maintains | Buy -> Buy |
| 2023-12-20 | Societe Generale | Maintains | Buy -> Buy |
| 2021-08-03 | Berenberg Bank | Initiate | |
| 2021-07-19 | UBS | Initiate | |
| 2021-07-19 | Berenberg Bank | Initiate | |
| 2021-06-29 | UBS | Initiate | Neutral |
| 2021-06-10 | JPMorgan Chase | Initiate | Buy |
| 2021-06-10 | RBC Capital | Initiate | Buy |
| 2021-03-24 | RBC Capital | Initiate | Buy |
| 2021-03-08 | JPMorgan Chase | Initiate | Buy |
| 2021-03-08 | Jefferies | Initiate | Buy |
| 2021-02-26 | Berenberg Bank | Initiate | Buy |
| 2021-02-09 | UBS | Initiate | Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 105.176B -14.01% | 83.674B -20.44% | 87.343B 4.38% | 98.602B 12.89% | 102.654B 4.11% | 110.005B 7.16% | 109.369B -0.58% | 140.122B 28.12% | 145.922B 4.14% | N/A | |
| EBITDA YoY % growth | N/A -12.21% | N/A 6.34% | N/A 10.24% | 11.568B 4.28% | 11.944B 3.25% | 12.479B 4.48% | 13.086B 4.86% | N/A | N/A | N/A | |
| EBIT YoY % growth | 10.933B 10.33% | 9.071B -17.03% | 10.795B 19.01% | 10.57B -2.08% | 10.728B 1.49% | 11.347B 5.77% | 11.905B 4.92% | 13.087B 9.93% | 13.608B 3.98% | 14.309B 5.15% | |
| Operating Margin | 10.39% | 10.84% | 12.36% | 10.72% | 10.45% | 10.31% | 10.89% | 9.34% | 9.33% | N/A | |
| EPS YoY % growth | 3.08 12.00% | N/A 10.30% | 3.59 5.67% | 4.02 7.52% | 4.26 10.45% | 4.56 7.01% | 4.90 7.44% | 5.04 2.85% | 5.33 5.78% | 5.65 5.86% |
All data in EUR
| Q2 / 26 | Q4 / 26 | Q2 / 27 | Q4 / 27 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 2.35 15.68% | 1.97 7.50% | 2.50 6.58% | 2.09 6.28% |
| Revenue Q2Q % growth | 39.376B -12.79% | 40.331B -21.34% | 40.94B 3.97% | 41.936B 3.98% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 6.439B 18.58% | 5.394B 4.86% | 6.743B 4.72% | 5.666B 5.04% |
All data in EUR
30 analysts have analysed CS.PA and the average price target is 46.89 EUR. This implies a price increase of 15.74% is expected in the next year compared to the current price of 40.51.
AXA SA (CS.PA) will report earnings on 2026-07-30.
The consensus EPS estimate for the next earnings of AXA SA (CS.PA) is 2.35 EUR and the consensus revenue estimate is 39.38B EUR.
The number of analysts covering AXA SA (CS.PA) is 30.